BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 17305407)

  • 1. Formation and accumulation of pyridyloxobutyl DNA adducts in F344 rats chronically treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Lao Y; Yu N; Kassie F; Villalta PW; Hecht SS
    Chem Res Toxicol; 2007 Feb; 20(2):235-45. PubMed ID: 17305407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of pyridyloxobutyl and pyridylhydroxybutyl DNA adducts in extrahepatic tissues of F344 rats treated chronically with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Zhang S; Wang M; Villalta PW; Lindgren BR; Upadhyaya P; Lao Y; Hecht SS
    Chem Res Toxicol; 2009 May; 22(5):926-36. PubMed ID: 19358518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of pyridylhydroxybutyl-DNA adducts in liver and lung of F-344 rats treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Upadhyaya P; Kalscheuer S; Hochalter JB; Villalta PW; Hecht SS
    Chem Res Toxicol; 2008 Jul; 21(7):1468-76. PubMed ID: 18570389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of pyridyloxobutyl DNA adducts in F344 rats chronically treated with (R)- and (S)-N'-nitrosonornicotine.
    Lao Y; Yu N; Kassie F; Villalta PW; Hecht SS
    Chem Res Toxicol; 2007 Feb; 20(2):246-56. PubMed ID: 17305408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinogenicity and DNA adduct formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F-344 rats.
    Balbo S; Johnson CS; Kovi RC; James-Yi SA; O'Sullivan MG; Wang M; Le CT; Khariwala SS; Upadhyaya P; Hecht SS
    Carcinogenesis; 2014 Dec; 35(12):2798-806. PubMed ID: 25269804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial DNA adducts in the lung and liver of F344 rats chronically treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and (S)-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Stepanov I; Hecht SS
    Chem Res Toxicol; 2009 Feb; 22(2):406-14. PubMed ID: 19166332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridylhydroxybutyl and pyridyloxobutyl DNA phosphate adduct formation in rats treated chronically with enantiomers of the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Ma B; Zarth AT; Carlson ES; Villalta PW; Stepanov I; Hecht SS
    Mutagenesis; 2017 Dec; 32(6):561-570. PubMed ID: 29186507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of pyridyloxobutyl DNA adducts of tobacco-specific nitrosamines in rat tissue DNA by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Lao Y; Villalta PW; Sturla SJ; Wang M; Hecht SS
    Chem Res Toxicol; 2006 May; 19(5):674-82. PubMed ID: 16696570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methyl DNA Phosphate Adduct Formation in Rats Treated Chronically with 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Ma B; Zarth AT; Carlson ES; Villalta PW; Upadhyaya P; Stepanov I; Hecht SS
    Chem Res Toxicol; 2018 Jan; 31(1):48-57. PubMed ID: 29131934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis and Identification of 2'-Deoxyadenosine-Derived Adducts in Lung and Liver DNA of F-344 Rats Treated with the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Carlson ES; Upadhyaya P; Villalta PW; Ma B; Hecht SS
    Chem Res Toxicol; 2018 May; 31(5):358-370. PubMed ID: 29651838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective metabolism and tissue retention in rats of the individual enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), metabolites of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Zimmerman CL; Wu Z; Upadhyaya P; Hecht SS
    Carcinogenesis; 2004 Jul; 25(7):1237-42. PubMed ID: 14988218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of O2-substituted pyrimidine adducts formed in reactions of 4-(acetoxymethylnitrosamino)- 1-(3-pyridyl)-1-butanone and 4-(acetoxymethylnitros- amino)-1-(3-pyridyl)-1-butanol with DNA.
    Hecht SS; Villalta PW; Sturla SJ; Cheng G; Yu N; Upadhyaya P; Wang M
    Chem Res Toxicol; 2004 May; 17(5):588-97. PubMed ID: 15144215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in bile duct-cannulated rats: stereoselective metabolism and tissue distribution.
    Wu Z; Upadhyaya P; Carmella SG; Hecht SS; Zimmerman CL
    Carcinogenesis; 2002 Jan; 23(1):171-9. PubMed ID: 11756238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pyridyloxobutyl DNA adduct, O6-[4-oxo-4-(3-pyridyl)butyl]guanine, is detected in tissues from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-treated A/J mice.
    Thomson NM; Kenney PM; Peterson LA
    Chem Res Toxicol; 2003 Jan; 16(1):1-6. PubMed ID: 12693024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of pyridyloxobutyl DNA adducts in nasal and oral mucosa of rats treated chronically with enantiomers of N'-nitrosonornicotine.
    Zhang S; Wang M; Villalta PW; Lindgren BR; Lao Y; Hecht SS
    Chem Res Toxicol; 2009 May; 22(5):949-56. PubMed ID: 19405515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of adducts produced by the reaction of 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanol with deoxyguanosine and DNA.
    Upadhyaya P; Sturla SJ; Tretyakova N; Ziegel R; Villalta PW; Wang M; Hecht SS
    Chem Res Toxicol; 2003 Feb; 16(2):180-90. PubMed ID: 12588189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass Spectrometric Quantitation of Pyridyloxobutyl DNA Phosphate Adducts in Rats Chronically Treated with N'-Nitrosonornicotine.
    Li Y; Ma B; Cao Q; Balbo S; Zhao L; Upadhyaya P; Hecht SS
    Chem Res Toxicol; 2019 Apr; 32(4):773-783. PubMed ID: 30740971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse.
    Upadhyaya P; Kenney PM; Hochalter JB; Wang M; Hecht SS
    Carcinogenesis; 1999 Aug; 20(8):1577-82. PubMed ID: 10426810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of pyridyloxobutyl-DNA adducts in tissues of rats treated chronically with (R)- or (S)-N'-nitrosonornicotine (NNN) in a carcinogenicity study.
    Zhao L; Balbo S; Wang M; Upadhyaya P; Khariwala SS; Villalta PW; Hecht SS
    Chem Res Toxicol; 2013 Oct; 26(10):1526-35. PubMed ID: 24001146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric analysis of relative levels of pyridyloxobutylation adducts formed in the reaction of DNA with a chemically activated form of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
    Sturla SJ; Scott J; Lao Y; Hecht SS; Villalta PW
    Chem Res Toxicol; 2005 Jun; 18(6):1048-55. PubMed ID: 15962940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.